Company Filing History:
Years Active: 2013-2017
Title: Prabakaran Mookkan: Innovator in Vaccine Development
Introduction
Prabakaran Mookkan is a distinguished inventor based in Singapore, known for his significant contributions to the field of vaccine development. He holds a total of five patents, showcasing his innovative approach to addressing public health challenges.
Latest Patents
Among his latest patents is the Monovalent H5 vaccine, which focuses on developing a vaccine strain using hemagglutinin (HA) engineering to elicit cross-clade protection against H5N1. This invention also includes an epitope-chimeric H5 and a reverse genetics influenza virus expressing this chimeric H5. Another notable patent is for a universal vaccine against H5N1 lineages, which identifies three H5N1 strains that encompass the variants in the neutralizing epitopes of hemagglutinin across most H5N1 lineages. This universal vaccine comprises these three strains or hemagglutinin peptides from each strain.
Career Highlights
Prabakaran Mookkan is currently affiliated with Temasek Life Sciences Laboratory Limited, where he continues to advance his research in vaccine technology. His work has been pivotal in developing innovative solutions to combat influenza viruses.
Collaborations
He collaborates with esteemed colleagues, including Hwei-Sing Jimmy Kwang and Fang He, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Prabakaran Mookkan's work in vaccine development exemplifies the impact of innovative thinking in addressing global health issues. His patents reflect a commitment to advancing medical science and improving public health outcomes.